Member Style: Award | MicroPort® Won “Shanghai Top Brand” for 12 Consecutive Years
Shanghai MicroPort Medical (Group) Co., Ltd. (“MicroPort®”) was recently awarded “Shanghai Top Brand” in 2017, according to a list released by the Shanghai Top Brand Recommendation Committee, for its English and Chinese brand name “MicroPort®” and “微创®” (recommended product: Rapamycin-Eluting Coronary CoCr Stent System). MicroPort® has been awarded such honor for 12 consecutive years since 2005. After the selection, the title will be valid till December 31, 2019.
Since its establishment in 1998, MicroPort® has been focusing on innovation. Currently, MicroPort® and its subsidiaries own a total of 1,900 issued patents, and have been granted several national science and technology achievements awards and provincial-level honors. With over 200 products, covering 10 major medical disciplines including interventional cardiology, orthopedics, interventional radiology, electrophysiology, diabetes and endocrine management, surgical management, and others, currently approved for use in over 5,000 hospitals in major markets such as Asia Pacific, Europe and America. MicroPort® is contributive to a better world through its life-saving medical therapies and quality-improving care devices used in patients every 15 seconds.
The title of “Shanghai Top Brand” signifies that the MicroPort® brand and its products are gaining higher social awareness, due to its industry-leading product quality and corporate governance. In the future, MicroPort® will continue to carry out the management credo of “Hands on Details, Eyes for Greatness” to offer cost-effective medical solutions to save or reshape lives or improve the quality of life for patients in China and worldwide.
